Premie Pouch to Manage Deformational Plagiocephaly in Very Low Birth Weight Infants
1 other identifier
interventional
11
1 country
3
Brief Summary
This pilot project proposes to develop and test a new device to manage (defined as resolving, prohibiting, inhibiting or preventing) the development of Deformational Plagiocephaly (DP) in prematurely born infants weighing \< 1 kilogram.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 28, 2017
CompletedFirst Posted
Study publicly available on registry
June 12, 2017
CompletedResults Posted
Study results publicly available
August 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedMarch 19, 2019
July 1, 2018
2 months
April 28, 2017
January 23, 2018
March 6, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Safety of Use of the Premie Pouch in VLBW Infants
Frequency of participants with adverse events reported using the Premie Pouch Adverse Event Data Collection Tool.
From date of enrollment to date of study completion (range 19-47 days)
Secondary Outcomes (4)
Feasibility of Use of the Premie Pouch in VLBW Infants
Number of hours per each 24 hour period on the device
Number of Participants With Normal Cranial Index
Cranial index at study completion
Number of Participants With Normal Cranial Symmetry
Cranial symmetry at study completion
Premie Pouch Ease of Use
From date of enrollment to date of study completion (range 19-47 days)
Study Arms (1)
Premie Pouch
EXPERIMENTALAll participants will receive the experimental treatment with the Premie Pouch device.
Interventions
The Premie Pouch is an experimental device meant to manage the development of Deformational Plagiocephaly (DP) starting immediately following birth. The Premie Pouch has a concave-shaped foam insert that will provide a resting surface for the infant's head and body that will eliminate uneven pressure on the infant's occiput while maintaining correct body alignment. Also, the posterior neck area of the infant will be supported by a fixed bridge section of the foam insert. The Premie Pouch is designed specifically for the very low birth weight (VLBW) infant.
Eligibility Criteria
You may qualify if:
- Infants weighing \</= 900 grams. (Selecting a weight below the 1 Kg cut off for using the device will allow the infant an opportunity to use the device before outgrowing it.)
- Infants born at \>/= 22 weeks gestation.
- Infants \</= 40 days of age at enrollment.
- Infants that receive medical clearance from their healthcare team.
- Infants that have an estimated minimum hospital length of stay = / \> 14 days from the time of enrollment.
- Every effort will be made to include infants from non-English speaking families as long as using all available resources; the parents can successfully communicate with the research team. The research team will utilize interpreter services and other resources (immediate family members and supports) to facilitate this process when applicable.
You may not qualify if:
- Infants that require only prone positioning to maintain airway patency (such as those with Pierre Robin Syndrome/Sequence) will not be eligible to participate; this is because infants must be able to lie supine for at least part of the day.
- Infants requiring medical devices such as a continuous ventricular drain, subgaleal shunt, or intravenous catheters (unless placement of the IV is temporary) as they prevent proper positioning using the Premie Pouch.
- Infants with a craniofacial anomaly, craniosynostosis, cervical anomaly, or critical airway.
- Infants with Cutis Aplasia or significant skin breakdown to the scalp, because the experimental device may worsen a preexisting condition.
- Infants that are to be transferred to a non-participating hospital within 14 days of enrollment as this timeframe may not allow adequate evaluation of the Premie Pouch.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- Boston Orthotics & Prostheticscollaborator
Study Sites (3)
Children's Hospital Boston
Boston, Massachusetts, 02115, United States
St. Elizabeth's Medical Center
Brighton, Massachusetts, 02135, United States
South Shore Hospital
Weymouth, Massachusetts, 02190, United States
Related Publications (3)
Seruya M, Oh AK, Sauerhammer TM, Taylor JH, Rogers GF. Correction of deformational plagiocephaly in early infancy using the plagio cradle orthotic. J Craniofac Surg. 2013 Mar;24(2):376-9. doi: 10.1097/SCS.0b013e31828010d1.
PMID: 23524697BACKGROUNDRogers GF, Miller J, Mulliken JB. Comparison of a modifiable cranial cup versus repositioning and cervical stretching for the early correction of deformational posterior plagiocephaly. Plast Reconstr Surg. 2008 Mar;121(3):941-947. doi: 10.1097/01.prs.0000299938.00229.3e.
PMID: 18317143BACKGROUNDDeGrazia M, Giambanco D, Hamn G, Ditzel A, Tucker L, Gauvreau K. Prevention of deformational plagiocephaly in hospitalized infants using a new orthotic device. J Obstet Gynecol Neonatal Nurs. 2015 Jan-Feb;44(1):28-41. doi: 10.1111/1552-6909.12523. Epub 2015 Jan 8.
PMID: 25573141BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michele DeGrazia
- Organization
- Boston Children's Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Michele DeGrazia, PhD, NNP
Boston Children's Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Nursing Research, Neonatal Intensive Care Unit
Study Record Dates
First Submitted
April 28, 2017
First Posted
June 12, 2017
Study Start
June 1, 2016
Primary Completion
August 1, 2016
Study Completion
March 1, 2019
Last Updated
March 19, 2019
Results First Posted
August 14, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share